Clinical Trial Update: Efficacy and Safety of DEH113 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating DEH113 for efficacy and safety in treating menstrual cramp pain due to primary dysmenorrhea; status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea

Drugs mentioned

• DEH113 (DEH113)

Snippet

Sponsor: EMS | Conditions: Primary Dysmenorrhea | Phase 3 | Status: NOT_YET_RECRUITING